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Treatment of rat thymus cell suspensions with dexamethasone resulted in inhibition of engaged RNA 
polymerase A, without significant change in free pool activity. Studies with the re-initiation inhibitor, 
rifamycin AF/O-13, and measurements of numbers of RNA polymerase A molecules and of elongation 
rates showed that the inhibition of pre-rRNA synthesis resulted from a decrease in elongation rate. This 
effect was selectively abolished by mild proteolysis of nuclei. It is concluded that glucocorticoid treatment 
of rat thymus cells suppresses 45 S rRNA synthesis primarily by decreasing the polyribonucleotide 
elongation rate, rather than by effecting a change in enzyme redistribution or concentration. 
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1. INTRODUCTION 
Previous studies have shown that treatment of 
rat thymus cells with glucocorticoids results in the 
transient stimulation of RNA polymerase B activi- 
ty within 10 min of steroid addition and is follow- 
ed by the inhibition of both RNA polymerase A 
and B activities [ 11. The glucocorticoid-specific in- 
hibitory effect on RNA polymerase A activity, 
unlike that on RNA polymerase B activity, is 
abolished by prior exposure of the cells to in- 
hibitors of mRNA and protein synthesis and by 
glucose deprivation [2,3]. These observations have 
therefore suggested that the effect depends on the 
steroid-induced production of mRNA and on its 
translation; evidence for the existence of 
glucocorticoid-induced proteins, which may 
regulate rRNA synthesis, has been obtained [4]. 
the polymerase, in comparison, is slow. In liver, 
for example, enzyme concentrations are not 
changed in response to short-term hormonal 
stimulation by glucocorticoids [5]. 
However, it is conceivable that the steroid ef- 
fects may be attributable to enzyme redistribution 
of RNA polymerase A between free and engaged 
pools. Such a mechanism has been proposed for 
the modulation of the rate of 45 S rRNA synthesis 
1671. 
The possibility that this hypothesis may relate to 
the inhibitory effects of glucocorticoids on RNA 
polymerase A activity, and hence rRNA synthesis, 
in rat thymus cells was therefore investigated. 
2. EXPERIMENTAL 
2.1. Reagents 
Furthermore, the inhibitory action of RNA 
polymerase A activity is unlikely to reflect changes 
in the total cellular content of the enzyme, since 
the effect occurs rapidly whereas the turnover of 
* Present address: Department of Physiology, Faculty 
of Medicine, University of Manitoba, 770 Bannatyne 
Ave., Winnipeg, Manitoba R3E 0W3, Canada 
[5-3H]UTP (2 Ci/mmol) was obtained from 
Amersham International (Amersham, England). 
ATP, CTP, GTP, UTP, poly[d(A-T)] and a- 
amanitin were purchased from Boehringer (Lewes, 
England). Trypsin, grade TRTPCK, was the pro- 
duct of Worthington (Freehold, NJ). Dexame- 
thasone (9u-fluoro-l&-methyl-l lp,17,21-tri- 
hydroxypregna-1,4-diene-3,20-dione) and ac- 
Published by Elsevier Science Publishers B. V. 
00145793/84/$3.00 0 1984 Federation of European Biochemical Societies 129 
Volume 173, number 1 FEBS LETTERS July 1984 
tinomycin D were supplied by Sigma (Kingston- 
upon-Thames, England). Medium 199 was ob- 
tained from Gibco Biocult (Paisley, Scotland). 
Rifamycin AF/O-13 was a generous gift from Dr 
R. Cricchio, Gruppo Lepetit, Milan, Italy. 
2.2. Preparation of rat thymus cells and nuclei 
Procedures for the preparation of rat thymus 
cell suspensions, in vitro incubations and the 
preparation of purified nuclei from cell suspen- 
sions have been described [I ,3]. 
2.3. DNA-dependent RNA polymerase assays 
Assay conditions for the determination of RNA 
polymerase A activity in purified nuclei have been 
described [ 1,3]. ‘Free’ RNA polymerase A activity 
was measured by the poly[d(A-T)]-actinomycin D 
technique [8-lo]. Polyribonucleotide elongation 
rates and numbers of RNA polymerase A 
molecules active in transcription in intact nuclei 
were determined as in [ 111. 
3. RESULTS 
3.1. Effect of dexamethasone on free and engaged 
pools of RNA polymerase A activity 
Free form RNA polymerase A activity was 
determined, simultaneously with that of the en- 
gaged form, in rat thymus nuclei in the presence of 
poly[d(A-T)] and actinomycin D (table 1). The 
concentration of inhibitor used (160 pg/ml) was 
capable of inhibiting endogenous rRNA synthesis 
in excess of 90’7’0, while the further addition of a 
saturating amount of poly[d(A-T)] (50 pg/ml) 
resulted in increased RNA polymerase A activity 
which was additive to, and did not inhibit or com- 
pete with, transcription of the endogenous tem- 
plate (not shown). In contrast to findings with rat 
liver nuclei [lo], rat thymus nuclei prepared by 
hypo-osmotic lysis of cells contained a substantial 
pool of free RNA polymerase A activity. This 
enzyme pool, however, was capable of diffusing 
from nuclei with comparative ease under iso- and 
hypo-osmotic conditions [lo]. Hence, free activity 
was also determined in the cytosol fraction re- 
maining after nuclei preparation. Treatment of rat 
thymus cells with 1 fcM dexamethasone for 3 h 
resulted in inhibition of the activity of the engaged 
form of RNA polymerase A by 30.0 + 5.4%, in- 
hibition of the nuclear free form by 11.2 + 9.0% 
and inhibition of free RNA polymerase A activity 
in the cytosol by 8.3 f 2.4% (table 1). 
Hence, total free activity was inhibited to essen- 
tially the same extent as that of nuclear and cytosol 
fractions. Under control conditions, RNA 
polymerase A activity of the free form was 2-fold 
higher than that of the engaged form; dex- 
Table 1 
Effect of dexamethasone on free and engaged RNA polymerase A activities in rat 
thymus cells 
Enzyme form RNA polymerase A activity Dexamethasone- No. of 
(pmol UMP/mg DNA treated (‘Yo of experiments 
per 15 min) control) 
Control + Dexamethasone 
Nuclear engaged 34.4 + 12.4 24.3 k 9.5 70.0 * 5.4 8 
Nuclear free 36.3 + 9.5 32.4 + 10.1 88.8 f 9.0 8 
Cytosol free 33.2 + 4.5 30.5 + 4.9 91.7 + 2.4 2 
Total free 69.5 62.9 90.5 
Total free/engaged 2.02 2.59 
Rat thymocytes were incubated for 3 h at 37°C with or without 1 gM dexamethasone. 
Nuclei were then prepared and free activity was determined, simultaneously with that 
of the engaged form, in the presence of poly[d(A-T)] (50gg/ml) and actinomycin D 
(160 fig/ml). The MgClz supernatant from the preparation of nuclei was the source of 
cytosol free enzyme. Activity of the free enzyme was referred to the DNA content of 
assayed nuclei. Results are mean values + SD 
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amethasone increased the ratio through suppres- 
sing endogenous UMP incorporation. 
In further experiments with solubilized 
chromatin-associated enzymes from 3-h-incubated 
rat thymus cells, no decrease in the concentration 
of engaged RNA polymerase A was detected after 
dexamethasone treatment; similar levels of the en- 
zyme were present in both control and steroid- 
treated cells (not shown). 
3.2. Effect of rifamycin AF/O-13 on control and 
dexamethasone-inhibited RNA polymerase A 
activity 
The inhibition of endogenous RNA polymerase 
A activity was not apparently due to enzyme 
redistribution, and therefore the effect of dex- 
amethasone on the engaged form was investigated 
under conditions of limited enzyme reinitiation. 
Rifamycin AF/O-13, a eukaryotic inhibitor of in- 
itiation, was used to suppress reinitiation of RNA 
polymerase A in the assay in vitro. Fig. 1 shows the 
activity of the engaged form of RNA polymerase 
A (RNA polymerase A II [lo]) in nuclei from rat 
thymus cells incubated for 3 h in the presence or 
absence of 1 PM dexamethasone. In the absence of 
rifamycin, the initial UMP incorporation rate in 
nuclei from steroid-treated cells was 62.5% of that 
in nuclei from control cells. Rifamycin AF/O-13 
did not affect initial synthetic rates, but prevented 
reinitiation by binding enzyme released after ter- 
mination of the polynucleotide chains [12]. In the 
presence of rifamycin (200 fig/ml), sensitivity to 
the inhibitor developed earlier in nuclei from con- 
trol cells than in nuclei from steroid-treated cells, 
. 
Incubation time (mid 
Fig.1. Effects of dexamethasone and rifamycin AF/O-13 
on RNA polymerase A activity in rat thymocyte nuclei. 
Rat thymocytes were incubated for 3 h at 37°C in the 
absence (m, 0) or presence (0, 0) of 1 pM 
dexamethasone; nuclei were then isolated and assayed 
for RNA polymerase A activity in the absence ( n , l ) or 
presence ( q , 0) of rifamycin AF/O-13 (2OOpg/ml). 
although similar levels of incorporation of UMP 
were attained. Furthermore, the effect of dex- 
amethasone on the plateau value of incorporation 
of UMP in the presence of rifamycin AF/O-13 was 
much less than the effect on the initial synthetic 
rate; the mean inhibition by dexamethasone at 
15 min was 7.3 + 1.4% (mean +- SD, n = 3). 
3.3. Effect of dexamethasone on numbers of RNA 
polymerase A molecules and elongation rates 
To substantiate the previous studies direct 
measurements were made of numbers of transcrib- 
ing RNA polymerase A molecules and of their 
elongation rates (table 2). Glucocorticoid treat- 
Table 2 
Effect of dexamethasone on number and elongation rate of form A RNA polymerases in rat 
thymocyte nuclei 
Dexamethasone UMP incorporated 10m3 x no. of trans- Polyribonucleotide 
(pmol/mg DNA cribing enzyme elongation rate 
per 7 min) molecules/cell (nucleotides/min) 
(olo control) (Yo control) (% control) 
_ 12.6 f 0.4 (100) 2.06 + 0.35 (100) 90.7 f 1.9 (100) 
+ 8.8 * 0.7 ( 70) 2.02 + 0.25 ( 99) 66.8 f 4.5 ( 74) 
Rat thymocytes were incubated for 3 h at 37°C with or without 1 pM dexamethasone. Nuclei 
were then prepared and assayed for RNA polymerase A activity. Simultaneously, numbers 
of transcribing RNA polymerase molecules and their elongation rates were determined. 
Results are mean values of duplicate experiments -t SD 
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Table 3 
Effect of treatment of nuclei with trypsin on RNA poiymerase A activity 
Dexamethasone Trypsin RNA polymerase A activity 
(pmol UMPlmg DNA per 15 min) 
(To control) 
Expt .1 Expt.2 
- 28.1 + 0.2 (100) 23.0 + 0.1 (100) 
+ 27.3 + 2.0 ( 97) 23.0 r?l 2.1 (100) 
+ 14.9 + 0.6 ( 53) 12.7 + 0.4 ( 55) 
+ + 27.2 k 2.1 ( 97) 20.0 rt 0.2 ( 87) 
Rat thymocytes were incubated for 3 h at 37’C with or without 1 /IM 
dexamethasone. Nuclei were then prepared and incubated for 4 min at 22°C in 
the presence or absence of trypsin (1.7pg/ml). TKMS [50 mM Tris-HCl (pH 
7.4), 25 mM KCl, 5 mM MgClz, 0.25 M sucrose] buffer (2 ml) was then added 
and the nuclei centrifuged at 800 x g for 2 min and redispersed in buffer for 
assay of RNA polymerase A activity. Results are mean values for duplicate 
nuclear preparations +: SD 
July 1984 
ment produced a reduction in the elongation rate, 
this decrease entirely accounting for the steroid- 
induced inhibition of nuclear RNA polymerase A 
activity. No change was observed in the number of 
transcribing enzyme molecules following dex- 
amethasone treatment. 
3.4. Effect of mild proteoiysis on RNA 
polymeruse A activity 
Previous studies of RNA polymerase A activity 
in rat liver [ 131 have shown that glucocorticoids in- 
crease the catalytic activity of the engaged enzyme, 
per se rendering this increased activity sensitive to 
mild proteolysis. Although glucocorticoids inhibit 
rat thymic RNA polymerase A activity, this ex- 
perimental approach was used to investigate the 
sensitivity of the thymic enzyme activity. Follow- 
ing the treatment of rat thymus cells with dex- 
amethasone for 3 h, RNA polymerase A activity 
was inhibited by 45.9 it 1.6% (mean + SD, n = 2) 
in trypsin-untreated nuclei (table 3). Strikingly, 
mild treatment of nuclei with trypsin did not affect 
control enzyme activity, but restored 
dexamethasone-inhibited activity to a value similar 
to that of control (91.9 f 3.3%; mean + SD, n = 
2). 
4. DISCUSSION 
The mechanism by which glucocorticoids 
132 
regulate RNA polymerase A activity in rat thymus 
cells has been under investigation for some time in 
this laboratory. In view of the extended half-lives 
of eukaryotic RNA polymerases, and the observa- 
tions that enzyme concentrations do not change in 
response to short-term stimulation by glucocor- 
ticoids [5], the effect of dexamethasone was 
studied on enzyme pool redistribution. 
Previous investigations of the control of 
ribosomal RNA synthesis have revealed the 
presence of two discrete pools of RNA polymerase 
A in eukaryotic cell nuclei [9]. One pool of enzyme 
exists as a tightly bound transcription complex 
(engaged form), while the other is ‘free’ with 
respect to its ability to transcribe an exogenous 
poly[d(A-T)] template in the presence of actinomy- 
tin D. Studies on the intranuclear distribution of 
RNA polymerase A revealed that the steroid-me- 
diated inhibition of the chromatin-bound form of 
the enzyme was not accompanied by significant in- 
creases or changes in free pool activity. However, 
since solubilized forms of free and engaged en- 
zymes retain a similar ability to transcribe purified 
DNA and synthetic templates [14,15], these results 
suggested that the glucocorticoid-induced inhibi- 
tion of RNA polymerase A activity was not simply 
a consequence of a decrease in number of initiated 
transcribing enzymes. 
Support for this conclusion was obtained from 
experiments using rifamycin AF/O-13 to suppress 
Volume 173, number 1 FEBS LETTERS July 1984 
re-initiation of RNA polymerase A in the assay in 
vitro (fig. 1). Clearly, the earlier onset of sensitivity 
to the inhibitor in nuclei from control cells than in 
nuclei from steroid-treated cells indicated the 
earlier release of active enzyme from ribosomal 
genes in control nuclei. Furthermore, since similar 
extents of incorporation of UMP were attained in 
the presence of rifamycin, these results are consis- 
tent with the conclusion that glucocorticoid treat- 
ment of rat thymus cells does not significantly af- 
fect average numbers of RNA polymerase A 
molecules transcribing, but inhibits rather 45 S 
rRNA synthesis by decreasing the enzyme elonga- 
tion rate. Direct measurements of the numbers of 
transcribing RNA polymerase A molecules and of 
elongation rates have subsequently confirmed 
these conclusions (table 2). 
Similarly, in liver, stimulated rRNA synthesis 
after in vivo glucocorticoid administration was 
observed to be due largely to increased engaged 
RNA polymerase A activity per se [ 14,161, rather 
than to increased availability of the ribosomal 
RNA genome [6,17]. This higher enzyme activity 
was reflected in the synthesis of longer RNA chains 
in vitro [ 18,191, presumably as a consequence of an 
increased polyribonucleotide elongation rate. 
Furthermore, modification of liver RNA 
polymerase A per se to a more active species has 
been observed [13]. Further experiments, using a 
similar experimental approach, were performed 
with thymus cells. Treatment of thymocyte nuclei 
with low levels of trypsin resulted in the restoration 
of dexamethasone-inhibited polymerase A activity 
to a value similar to that of control. No significant 
effect of proteolysis was observed on control en- 
zyme activity. These results are essentially similar 
to those obtained for rat liver cells, although in this 
tissue glucocorticoids stimulate ribosomal RNA 
synthesis [131. Nevertheless, conversion of existing 
RNA polymerase A to a form with different 
catalytic activity and altered sensitivity to pro- 
teolysis appears to be a common property of this 
mechanism in both tissues. The enzyme activity 
may be regulated by a glucocorticoid-induced pro- 
tein labile to mild proteolysis. 
From these results, we conclude that glucocor- 
ticoid treatment of rat thymus cells inhibits 45 S 
rRNA synthesis primarily by decreasing the 
polynucleotide elongation rate of RNA polymerase 
A, probably by modification of the enzyme. 
Whether this mechanism requires the cooperation 
of RNA polymerase B activity to mediate the hor- 
monal effect [3,20], or whether glucocorticoids can 
directly affect the synthesis of ribosomal RNA [ 191 
in thymus cells, remains to be resolved. 
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